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Background: Malaria in pregnancy remains a major health problem. Placental malaria infection may cause
pathophysiological changes in pregnancy and result in morphological changes to placental villi. Quantitative
histomorphological image analysis of placental biopsies was performed to compare placental villous architecture
between active or treated placental malaria cases and controls.
Methods: A total of 67 placentas were studied from three clinical groups: control patients who did not have
malaria (n = 27), active (n = 14) and treated (n=26) malaria cases, including both Plasmodium falciparum and
Plasmodium vivax infections. Image analysis of histological placental sections was performed using ImageJ software
to measure the number and size (area) of terminal villi, perimeter measurement per villus and total perimeter per
unit area, and number of capillaries per villus (vascularity). Histological features of placental malaria were scored and
these results were correlated with malaria status and clinical outcomes.
Results: Villous size correlated with vascularity (p <0.0001) but was inversely correlated with observed villi per unit
area, (p = 0.0001). Significantly greater villous area and vascularity was observed in UK controls. Indices of
histological malaria infection were significantly greater in active versus treated malaria cases. Active placental
malaria cases showed significantly smaller villous area (p <0.0084), vascularity (p <0.0139) and perimeter (p <0.0006)
than treated malaria cases or controls, but significantly more villi per unit area (p <0.0001). Villous size in treated
malaria cases was significantly larger than active placental malaria cases (p <0.001) and similar to controls. There
was a significant relationship between villous number and anaemia at the time of infection (p <0.0034), but not
placental weight, birth weight or gestational age at delivery. No differences were found between histology or
villous morphology comparing infections with P. falciparum or P. vivax.
Conclusions: These results imply that villous size, perimeter and vascularity are acutely decreased during active
placental malaria, decreasing the surface area available for gas exchange per villus. However the increased number
of villi per unit area offsets this change and persists after treatment. Histopathological and villous architectural
changes may be reversed by early detection and appropriate anti-malarial treatment.
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Malaria infection during pregnancy is a major public health
problem in tropical and subtropical regions throughout the
world, with substantial risks for the mother, her foetus and
subsequently the neonate [1]. Malaria in pregnancy, defined
as malaria infection in the placenta or maternal blood at
any time during gestation, is associated with a number of
materno-foetal complications, such as intra-uterine growth
restriction (IUGR), anaemia and pregnancy loss [2-5]. The
structure of the placental villous tree changes during nor-
mal placental development due to major physiological
changes occurring in the placenta during maturation,
reflected in changes to the morphology of the stem, inter-
mediate or terminal villi and blood vessels within them
[6-8]. Placental malaria, namely the presence of parasit-
ized erythrocytes in the placenta, is inferred to occur dur-
ing maternal malaria infection, but is only histologically
confirmed if parasites are present on histological examin-
ation of the placenta following delivery.
Placental malaria infection causes pathological changes
such as inflammation, intervillous fibrin deposition and
infarction, that can persist until delivery and affect the
function of the materno-placental unit, contributing to
adverse birth outcomes and increased perinatal mortality
and morbidity [9]. However the effect of malaria infec-
tion on villous architecture has not been studied in
depth. Previous studies have used histomorphometric
image analysis to examine placental villous architecture
in other diseases causing IUGR, including pre-eclampsia
(PE) and diabetes [10-16]. There are a number of physio-
logical factors that can affect villous architecture, as mea-
sured on image analysis. Both the age and parity of the
mother have been shown to affect villous numbers and
vascularity. For instance, the volume density of capillaries
in terminal villi was shown to be significantly lower in
older women in comparison to the placenta in younger
mothers [7]. In idiopathic IUGR, the number of capillaries
in the terminal villi and the villous area was significantly
decreased compared with controls appropriate for gesta-
tional age group [10,11]. In PE, the villous area and vascu-
larity were significantly smaller than controls [13]. This
study aimed to examine villous architecture and vas-
cularity in placental malaria, relate these to clinical
outcomes and the patterns of histopathological changes
that have been characterized previously in malaria. It also
sought to determine whether any such changes differed
between infections with either Plasmodium falciparum
and Plasmodium vivax, or were ameliorated by effective
anti-malarial treatment before delivery.
Methods
Ethical approvals
Ethical permission for collection of placental biopsies in
the specific studies was granted with each separate study[17-21]. Use of these data and specimens in this morpho-
metric study was approved by the Ethics Committee of
Faculty of Tropical Medicine, Mahidol University (TMEC
12–027).
Patient selection and clinical groups
In this study a total of 67 placental biopsies were ex-
amined, from cases that were divided into three main
clinical groups – non-malaria controls (n = 27), active
placental malaria cases (n = 14) and treated malaria
cases (n = 26).
The active or treated malaria-infected patients (n = 40)
included n = 26 who had only P. falciparum infection,
n = 5 with mono-infection by P. vivax and n = 9 with
consecutive or mixed P. falciparum/P.vivax infections.
Of this latter group, n = 7 had multiple consecutive
infections, including at least one episode each with ei-
ther P. falciparum and P. vivax, and two of whom had
proven mixed infections with both organisms simultan-
eously. Details of the malaria status of the cases are shown
in Figure 1.
Placental biopsies were collected between 2004–2011,
from the Department of Tropical Pathology, Faculty of
Tropical Medicine and three previously published studies
investigating malaria in pregnancy conducted at Shoklo
Malaria Research Unit (SMRU) field research station at
Mae Sot, Thailand. These were studies of the histopath-
ology of placental malaria, used to identify cases with
acute infection at delivery with both P. falciparum and
P. vivax [17], an observational ultrasound in pregnancy
study (UPS) [18,19] and the artemether-lumefantrine
treatment of malaria study (PCA) [20,21]. Women in
these studies included ethnic Karen refugees and mi-
grants from an area of approximately 120 km around the
border between Thailand and Myanmar, surrounding the
town of Mae Sot and the Maela refugee camp. They
attended weekly antenatal clinics for malaria screening
and all parasitaemic episodes were treated according to
WHO guidelines. As a comparator group for villous
morphology in a geographically distinct group of normal
control non-malaria cases, a series of normal placental
biopsies from the UK were also examined.
The cases included:
(i) Control normal placentas from UK women delivering
at The John Radcliffe Hospital, Oxford, UK (n = 9),
with no fever complicating pregnancy or delivery.
(ii) Control placentas from Karen women delivering at
SMRU, who had no evidence of malaria infection by
active screening by microscopy throughout
pregnancy and negative histology at delivery
(n = 18, from UPS study).
(iii)Active placental malaria cases (n = 14), where
malaria was diagnosed by microscopy and
Figure 1 Flow chart showing the type and number of the cases in active and treated malaria and control groups.
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biopsies confirmed acute placental malaria infection
at the time of delivery (from histopathology and
UPS studies).
(iv)Cases with known single or multiple malaria
infections treated during pregnancy at various time
points prior to delivery (n = 12, from UPS study,
n = 3 of whom had active placental malaria at
delivery and are therefore already included in group
iii above).
(v) Single-treated malaria infection in early, middle or
late pregnancy (from PCA) but not at delivery
(n = 17), selected randomly from patients where
mono-infection was proven and subsequent
screening microscopy until delivery was negative
[19]. ‘Early’ infection (n = 6) included women who
had a clinical episode of malaria treated at least five
months prior to delivery; ‘middle’ (n = 6) included
those with malaria infection two to four months
before delivery and ‘late’ infection (n = 5) those with
treated malaria infection within one month before
delivery.
Clinical outcome data on the patients included the
gestational age at delivery (EGA), the placental weight atdelivery (in grams), the birth weight of the baby (in
grams), and the presence of maternal anaemia at the time
of infection. This was measured using standard haemato-
crit (HCT) measurement, and stratified according to the
criteria used at SMRU for defining maternal anaemia 1:
HCT > 30% - normal, 2: HCT 25-30% - mild anaemia and
HCT < 25% - severe anaemia. EGA was measured for all
Mae Sot patients by dating ultrasound prior to 24 weeks,
Dubowitz estimation of gestational age and the last men-
strual period. Because malaria in this study group was
diagnosed actively and prospectively, and treated when
found regardless of symptoms, the possibility of asymp-
tomatic placental infection at delivery was minimal. Each
case was defined at delivery as being malaria negative on
the basis of smear microscopy on cord blood, maternal
blood and placental smears. Summary details of the clin-
ical groups are shown in Table 1.
Specimen preparation
Placental biopsy samples were taken by trained personnel
according to established protocols, taking a full thickness
biopsy including maternal and fetal surfaces, half way
between the placental edge and the cord insertion site.
Specimens were fixed in 10% neutral buffered formalin
(UPS, and histopathology study and UK control patients)
Table 1 Descriptive data summarising the different clinical groups by malaria status
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embedded in wax and processed using standard histo-
logical techniques to produce paraffin blocks. All pro-
cessing and histological staining was performed in batches
at the same pathology laboratory. Four μm histological
sections were cut on a rotary microtome, and stained with
both haematoxylin and eosin and Giemsa for histological
examination.
Image analysis of placental villi
The morphological study examined terminal, as opposed
to stem or intermediate villi, because previous studies
on the effects of disease on villous morphometry, and a
pilot study in these cases, indicated that the predomin-
ant changes caused by disease are seen in these villi.
Terminal villi were identified using a series of criteria in-
cluding thinned trophoblastic lining, lack of muscular-
ized arterioles, and more than 50% of the cross sectional
area being occupied by vessels [8].
A total of 67 placenta specimens were used for image
analysis by assessing four main parameters: the cross
sectional surface area (size) of terminal villi; the number
of capillaries per terminal villus; the number of terminal
villi per high powered field (hpf ); and the perimeter
measurement of terminal villi, both the mean perimeter
of individual villi and the total perimeter measurement
in ten hpf.Figure 2 Image processing steps used to generate quantitative outpu
various stages of processing are graphically illustrated in the following sequ
following removal of partial outlines and non-terminal villi; (C) adjusted th
measurement of area of terminal villi using the resultant outlines.Tissue sections were examined and digital images were
captured from ten randomly selected ×400 hpf per slide
using an Olympus DP-20 colour video camera interfaced
with an Olympus BX41 microscope. The images were
scanned at a resolution of 1,600 × 1,200 pixels using
Olympus DP-20 BSW software (Version 2.2) and stored.
Only the intermediate zone of the placenta was used and
areas where villi could not be distinguished, with placen-
tal infarction, intervillous fibrin deposition, or arterial
vessels forming the primary stem and intermediate villi
were avoided, as these can distort the observed villous
size [7,13]. Only terminal villi showing outlines com-
pletely within the microscopic field were counted. Cap-
tured images were used as raw data to quantify the villous
architecture using the image analysis software ImageJ
(Version 1.46, NIH, Maryland, USA) and to measure the
area of terminal villi (μm2), number of capillaries per ter-
minal villous and perimeter of terminal villi (μm).
Area of the terminal villi (μm2)
The images were first subjected to a preprocessing step
(Figure 2) which involved the removal of non-relevant
areas to leave only single terminal villi outlines, using an
eraser tool in Photoshop (Version CS6, Adobe System
Inc., California, USA) software. Images were then ad-
justed by ImageJ to convert them to greyscale 8-bit im-
ages. After adjusting the threshold, the area of terminalts from haematoxyling and eosin-stained placental sections. The
ence: (A) original image (magnification x400); (B) preprocessing step
reshold to generate solid red pixelated areas; (D) computerized
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The mean area of terminal villi for a case was calculated
by the ratio between the total area and number of ter-
minal villi in the field across all ten hpf.
Number of capillaries per villous (villous vascularity)
The villous vascularity was measured using the cell
counter tool in ImageJ to count the number of open ca-
pillary spaces, lined by endothelium, in each villous (re-
gardless of whether this contained erythrocytes or not).
The number of capillaries per villous was calculated by
the total number of villous vessels divided by the num-
ber of terminal villi across ten separate hpf.
Number of terminal villi per high-powered field (hpf)
The number of terminal villi in ten hpf was counted by
eye with light microscopy in each case. The mean num-
ber of terminal villi per hpf in each patient was calcu-
lated by the ratio between the total number in ten hpf/
ten. Results for individual cases were then combined for
comparison between clinical groups.
Perimeter measurement of villi
The perimeter of terminal villi (in μm) was measured in
two ways. The mean perimeter measurement of individual
villous cross sections (for all villi in ten hpf) was calcu-
lated automatically in a similar manner to the villous area
by ImageJ, directly from the outlined edge of terminal villi
(Figure 2D). The total perimeter measurement of all vil-
lous cross sections in ten hpf was also calculated.
Histological scoring of changes in placental malaria infection
The scoring system of Muehlenbachs et al. [22] was
used to grade the presence or absence of parasitized red
blood cells (PRBC), the density of inflammation and the
presence of haemozoin pigment in intervillous fibrin.
Semiquantitative scores for inflammation and pigment
were also generated for each case (the histoscore). When
present, infected erythrocytes were used to estimate a
parasitaemia of infection in the placenta by counting in-
fected and uninfected red blood cells over 100 hpf and
calculating the percentage of RBCs infected.
Statistical analysis
The specimens were prepared and analysed blind to
the clinical group. Analyses were performed using the
statistical program SPSS version 18 (SPSS Inc, Chicago,
Illinois, USA) for Windows and STATA v12.0 (StataCorp
LP, College Station, TX, USA). Data were described using
means (standard deviation-SD) and frequencies (%). Due
to the relatively small sample size and unequal variances
across groups, non-parametric tests were used for com-
parisons. Correlations between villous number, size and
vascularity and between clinical groups, across allindividuals and between clinical outcome measures, were
assessed using Kendall’s rank correlation coefficient (tau).
The relationship between histoscore parameters and mea-
sures of villous architecture between clinical groups,
subgroups of the PCA cases, and with clinical outcomes
such as anaemia, was performed using the Fisher’s exact
test and the Kruskall-Wallis test. Differences were consid-
ered statistically significant for p-values less than 0.05.
However, as this was an exploratory study, numerous
comparisons were made and exact p-values (to the third
decimal place) are reported so that the reader may apply
Bonferroni corrections, if preferred (where the statistically
significant p-value is calculated as α/n, where α = 0.05 and
n = number of tests).
Results
Maternal malaria in southeast Asia differs from the
African setting in that the disease is not endemic, there
is a substantial proportion of P. vivax as well as P. falcip-
arum infections, and also mixed infection with both or-
ganisms. In addition the patients included in this study
were frequently tested for malaria and treated when this
was detected, so active placental malaria at delivery is
rare and the duration of undiagnosed malaria infections
during gestation is minimal [17]. In malaria-infected
cases, including both active and treated patients (a total
of eighty-six infective episodes) the mean maternal para-
sitaemia on diagnosis was 21,308/μl (+/− SD 102,150).
Correlation between villous area, vascularity and villous
number
There was a significant inverse correlation between
villous area and villous numbers observed per hpf
(Kendall’s tau = −0.3216; p = 0.0001) either examining
all cases or individual clinical groups (Figure 3A), be-
cause larger villi meant that less villi were seen per
hpf at a given magnification. These two measurements
were therefore covariate and not independent as an out-
come measure of placental pathology. Conversely, there
was a significant positive correlation between villous area
and villous vascularity (Kendall’s tau = 0.4799; p <0.0001)
(Figure 3B).
Fixation and geographical origin influence observed
villous architecture
Several other potentially confounding factors influenced
the observed villous area. The first was the method of
fixation. Non malaria-infected Thai/Karen cases fixed in
formalin had a non-significantly lower mean villous area
than cases fixed with Streck’s solution (p = 0.0842) but
significantly lower villous vascularity (p <0.0002). In
addition, the UK control group had a significantly
greater villous area (p <0.0004) and villous vascularity
(p <0.0087) than Thai/Karen control cases indicating a
Figure 3 Correlations between the villous area, number of villi per high-powered field and villous vascularity. 3 A – Dot plot showing
the negative correlation between the villous area and observed number of villi per hpf in individual cases (Line = line of best fit, Spearman rank
correlation coefficient rho = −0.425, p <0.0001). 3 B – Dot plot showing the positive correlation between the villous area and villous vascularity in
individual cases (Line = line of best fit, Spearman rho = 0.668, p <0.0001).
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basis (Figure 4). Other placental villous architectural fea-
tures, such as number of villi/hpf and perimeter mea-
surements, were not significantly different between the
two control groups. One potential explanation for this
might be villous congestion in UK deliveries due to de-
layed clamping of the umbilical cord, which was notFigure 4 Boxplot graph comparing villous area between clinical grou
or geographical origin. A boxplot showing the distribution of villous area i
cases fixed with formalin, divided into control non-malaria infected and malar
fixative), and active placental malaria cases (Thai/Karen cases also fixed
than other groups (p <0.0004). PCA cases showed a non-significantly h
Active placental malaria cases showed significantly lower villous areas than
include; line =median, upper and lower bar = 25 and 75th centiles, respective
maximum and minimum values.practised in Karen women at the time these samples were
collected. UK control cases had higher body weights than
Karen controls, but the placental weights at delivery be-
tween these populations was not significantly different.
A post-hoc analysis of the results comparing UK con-
trols, UPS, PCA and active malaria groups separately con-
firmed the significant differences in villous morphologyps of controls and cases derived from different fixative methods
n sq μm between groups including UK controls, UPS cases (Thai/Karen
ia -infected UPS cases), PCA cases (Thai/Karen cases fixed with Streck
with formalin). UK controls showed significantly higher villous area
igher villous area than UPS controls fixed in formalin (p <0.0842).
all other groups *. Box and whisker plots for this and subsequent figures
ly, with shaded box covering interquartile range; whiskers cover
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method. Therefore, despite the differences in villous archi-
tecture caused by the fixation method and geographical
origin of the patient, outlined above, the analysis of the
clinical groups compared combined control cases (UK
and Thai/Karen controls; patients with no malaria infec-
tion) with all treated malaria cases (proven malaria infec-
tion at some point in gestation detected by screening and
treated, but no observable PRBCs in the placenta at deliv-
ery) and active placental malaria cases (where histological
evidence of parasites within the placenta confirmed acute
malarial infection at delivery).
Changes in villous architecture in malaria cases
There was a significant decrease in villous area in active
malaria-infected cases compared to both controls and
treated malaria cases (p = 0.0084) (Figure 5A, Table 2).
The number of capillaries per terminal villous (villous
vascularity) in the malaria-infected patients was also sig-
nificantly decreased compared to controls or treated
malaria cases (p = 0.0139) (Figure 5B, Table 2).
The number of villi seen per hpf was significantly in-
creased in both in active and treated malaria cases com-
pared to non-malaria controls (p <0.0001) (Figure 5C,Figure 5 Boxplot graphs showing variation in placental villous morph
There was a significantly lower villus cross sectional area in active malaria c
test). 5 B - Villous vascularity. There was a significantly lower number of cap
malaria (*p <0.0139, Fisher’s exact test). 5 C: Number of villi per high-powe
in both active and treated malaria cases compared to controls (*p <0.0001
was a significantly lower perimeter measurement per individual villus seen
(*p <0.0006, Fisher’s exact test). 5 E - Total perimeter measurement for all vil
of all villi seen per 10 hpf in both active malaria and treated malaria cases comTable 2). The perimeter measurement of individual villi
was significantly decreased in malaria cases compared to
treated malaria cases or controls (p < 0.0006, Figure 5D,
Table 2) but conversely the total perimeter measurement
of all villi/10 hpf was significantly higher in both treated
and active malaria groups than uninfected controls
(p <0.0004, Figure 5E, Table 2).
Villous size and vascularity was reduced in acute pla-
cental malaria cases. The number of villi observed per
hpf increased significantly in malaria cases even after
treatment, and this effect lasted until delivery. However
other changes such as the acute decrease in villous size
and changes in vascularity, and the histological fea-
tures of placental malaria, resolved given early detec-
tion and appropriate treatment. In addition, although
these smaller villi in malaria cases showed a lower
perimeter measurement, the total perimeter available
for gas exchange per unit area was increased, possibly a
compensatory mechanism.
These results are different to those reported by Crocker
and colleagues [23], who showed similar villous numbers
between non-infected placenta, malaria infected, past in-
fected and active infected placenta, using the histopatho-
logical classification system of Bulmer et al. [24]. In theological parameters between clinical groups. 5 A - Villous size.
ases compared to control or treated malaria (*p <0.0084, Fisher’s exact
illaries per villus in active malaria cases compared to control or treated
red field. There was a significantly higher number of villi seen per hpf
, Fisher’s exact test). 5 D: Mean perimeter measurement per villus. There
in active malaria cases compared to treated malaria cases and controls
li in 10 hpf. There was a significantly higher total perimeter measurement
pared to controls (*p <0.0004, Fisher’s exact test).
Table 2 Comparison of histoscore variables and measures of villous architecture between different clinical groups
Variable Controls vs Treated malaria
vs Active malaria
P. falciparum vs
P. vivax or Mixed Pf/Pv
Subgroups of PCA patients –
Treated Pf Early/Mid or late in gestation
HISTOSCORE
Presence of parasitized erythrocytes <0.001** 1.000 N/A (all –ve)
Inflammation <0.001** 0.177 0.382
Pigment <0.001** 1.000 0.471
Parasitaemia 0.0001** 0.855 N/A (all –ve)
Inflammation score (I-III) 0.001** 0.346 0.481
Pigment score (I-III) 0.0002** 0.613 0.335
IMAGE ANALYSIS
Villous area (mm2) 0.0084** 0.321 0.554
Villous vascularity 0.0139* 0.094 0.667
Villi/hpf 0.0001** 0.321 0.235
Perimeter/villous (mm) 0.0006** 0.629 0.203
Total perimeter mm/10 hpf 0.0004** 0.119 0.523
Pf = P. falciparum, Pv = P. vivax, *P < 0.05, **P < 0.01 N/A = Not Applicable.
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in villous architecture were seen associated with active
malaria infection, which resolved in treated malaria infec-
tion, apart from the observed number of villi/hpf.
Histological scoring of placental pathological changes
The pathological changes associated with placental mal-
aria were scored according to the system of Muehlenbachs
et al. [22]. The presence of parasites (p <0.001), degree of
inflammation (p <0.001) and presence of parasite-derived
haemozoin pigment (p <0.001) were all significantly differ-
ent between active and treated malaria-infected cases. The
inflammation score (p = 0.001) and degree of parasitaemia
in the placenta (p = 0.0002) were also significantly associ-
ated with placental malaria infection (Table 2).
Analysis of clinical outcomes and villous architecture
There were no significant differences between the demo-
graphic details of the different clinical groups (Table 1)
other than the maternal haematocrit, which was signifi-
cantly higher in control cases than malaria treated or in-
fected cases (p < 0.0034). A number of other factors have
been previously shown to influence villous size and archi-
tecture in other diseases, such as the gestational age of the
placenta and placental weight at delivery. There was a
small and (after correction for multiple comparisons)
probably non-significant decrease in villous size associated
with gestational age at delivery (p <0.043).
Malaria is the single greatest risk factor for anaemia in
pregnant Karen patients and reversal is slow even when
malaria and anaemia are treated [19,25]. Because an-
aemia might cause relative hypoxia within the placenta
over a longer period, influencing villous size, the degree of
anaemia in the mother (as measured by the haematocritof the patients at the time of infection) was also correlated
with the various measures of villous development above
(area, number, vascularity and perimeter measurements).
These results are shown in Table 3. There was a signifi-
cant relationship between the degree of maternal anaemia
at the time of infection (whether measured by absolute
haematocrit or graded) and the subsequent number of ob-
served villi at delivery, such that patients with moderate to
severe anaemia at the time of infection had significantly
more villi/hpf at delivery (p = 0.0034) compared to unin-
fected controls (Figure 6). However no relationship was
seen between villous size, vascularity and perimeter and
the placental weight, maternal anaemia, gestational age or
birth weight. The increase in villous numbers was also
seen in treated malaria cases. These results suggest that
changes to villous architecture may be dependent not only
on malaria infection itself but on concomitant malaria-
induced anaemia, and persist despite effective treatment
of the acute infection.
Histology and placental villous architecture are similar in
Plasmodium falciparum or Plasmodium vivax
The relationship between villous architectural changes
and the type of malaria infection was examined in
malaria cases, for both monospecies infections with
P. falciparum (n = 26) or P. vivax (n = 5), and where
patients had both species either on separate occasions
during gestation or mixed infection with both (n = 9).
No significant differences were seen between any of the
placental architectural parameters and either mono-
infection with either P. falciparum or P. vivax, or in preg-
nancies where both species had been found, either as a
mixed infection or on separate occasions (Table 2). The
comparison of the morphological changes in the placenta
Table 3 Correlation of villous architecture with clinical outcomes







(total per 10 hpf)
Placental weight 0.995 0.547 0.975 0.761 0.208
Gestational Age at delivery 0.043* 0.364 0.247 0.968 0.310
Maternal anaemia Gradea 0.656 0.354 0.0034** 0.525 0.214
Maternal haematocrit %b 0.142 0.922 0.009** 0.760 0.346
Birthweight 0.833 0.567 0.441 0.454 0.179
aMaternal anaemia graded by haematocrit at infection (0 = normal, 1 = 25-30%, 2 = <25%, see Methods).
b% maternal haematocrit at infection.
Figures in bold are significant at *P<0.05 and **P<0.01.
Chaikitgosiyakul et al. Malaria Journal 2014, 13:4 Page 10 of 13
http://www.malariajournal.com/content/13/1/4in this study is however necessarily limited by the small
number of samples from P. vivax patients, which could
generate a bias in the analysis.
Histological descriptions of pure P. vivax placental
malaria are so far limited [17,26-28]. Patients who had
sequential (not simultaneous) P. falciparum and P. vivax
infections occurring at different times in the same gesta-
tion appeared similar histologically, whichever infection
was first, without differences in the degree of inflamma-
tory response. Whether multiple recrudescent infections
have clinically or pathologically different results from
mono- or true dual infection remains to be determined.
Relationship between timing of infection and delivery
In PCA patients, all of whom had mono-infection with
P. falciparum, selection was according to the timing of
the last treated malaria infection compared to delivery.
These groups were divided into ‘early’ (n = 6 women
who had a clinical episode of malaria treated at least fiveFigure 6 Boxplot graph of villous number per high-powered field com
showing the significantly higher number of villi seen per 10 hpf in cases w
(*p <0.0034, Fisher’s exact test).months prior to delivery and no subsequent infections);
‘middle’ (n = 6 included those with malaria infection two
to four months before delivery) and ‘late’ infection (n = 5
those with treated malaria infection within one month
before delivery). Comparison showed no significant dif-
ferences between timing of infection before delivery and
any of the parameters of the histoscore or villous archi-
tecture (Table 2), although the groups were small.
Because pathology at a given point in gestation can
cause placental insufficiency, fibrinoid necrosis and scar-
ring, subsequent development may be affected even if
the infection is treated, and still be seen histologically at
delivery some time later. However when groups of pa-
tients within the PCA study were compared, all of whom
had been infected, diagnosed and treated for malaria but
at varying times in gestation before delivery, there were
no differences in villous architecture or resultant histo-
score in the placenta at delivery. The similarity of both
villous architecture and histoscore of treated placentalpared to maternal anaemia at the time of infection. Boxplot
ith mild and severe anaemia compared to patients without anaemia
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aria infection is detected and treated effectively, the
placenta retains enough compensatory mechanisms to
return to normal growth and development without
long-term pathological changes caused by untreated
malaria infection.
The acute reduction of villous size and perimeter asso-
ciated with active malaria infection seems unlikely to re-
flect decreased blood flow in the placenta before delivery
(for instance due to the effects of vascular obstruction
by sequestered parasites, leukocytes or fibrin deposition)
because these processes affect the maternal blood space.
Changes in villous vascularity and size in other diseases
examined using morphometry developed over a longer
period due to poor oxygenation and hypertension, lead-
ing to defective stem villous development and hence
vascularization of terminal villi [16,29,30]. Apart from
blood flow, the activity of various growth-promoting
hormones, such as insulin-like growth factor or placental
growth factor, plays a role in supporting normal placen-
tal development [31], but changes in these growth axes
would not explain the acute shrinkage seen in malaria
infection. This study specifically examined changes in
terminal villi only, and therefore excluded areas that
may be affected by other pathological changes caused by
placental malaria infection, such as infarction or exten-
sive intervillous fibrin deposition. Such changes also
have an important effect on placental function and the
extent of these lesions is another important factor affect-
ing the structure and function of the remaining placenta.
Villous size was interdependent with villous vascular-
ity. If there was a generalized decrease in villous vessel
numbers in malaria infection this may cause an acute
shrinkage of villous area, which seems more likely than
a sudden loss of established villous blood vessels. Placen-
tal malaria infection causes acute changes to both mater-
nal and foetal haemodynamics, which reverses rapidly,
within three days, after effective treatment [32,33].
Foetal heart rate is increased and it may be that other
physiological parameters of the foetal-maternal circula-
tion in the placenta, such as blood pressure, are altered
in acute infection. Whether this reduces the perfusion
pressure of the villi or causes changes to villous size,
which are maintained and seen on subsequent histology,
is unclear. Ultrasound Doppler investigation of the pla-
centa during acute malaria also shows that malaria is as-
sociated with significantly smaller placental volumes,
which can be linked to subsequent IUGR and poor out-
come [34].
The pathophysiological effects of malaria infection
in the placenta include inflammatory cell localization,
cytokine release and direct effects on villous function
by parasitized erythrocyte binding [35-38]. Cytokine
and chemokine release, induced in host leukocytes andsyncytiotrophoblastic cells and enhanced by phagocytosis
of malaria pigment [39], causes auto-induction of chemo-
kines and angiogenic factors which can attract host mono-
cytes [40]. In other organs where PRBC and leukocytes
are sequestered, signalling across endothelial monolayers
causes changes to interendothelial cell junctions and
oedema formation, such as in the brain during cerebral
malaria [41]. There is evidence that adhesion of PRBC to
syncytiotrophoblastic cells initiates signalling in these cells
by tyrosine phosphorylation [42]. The current findings
suggest another potential mechanism for placental dys-
function during malaria infection, where the presence of
PRBC and host leukocytes reduces villous surface area, es-
sential for foeto-maternal transfer of gas or nutrients, and
disposal of potentially toxic metabolites, affecting foetal
growth and development in undiagnosed or recurrent in-
fections. This may result from either increased external
osmotic pressure on the villus, or changes to foetal and
maternal blood pressure reducing vascular filling, causing
acute shrinkage. However the increase in relative villous
numbers and therefore total available villous perimeter
per unit area, which persists after treatment of infection
through to delivery, hints at an attempt at compensation
for this.
Conclusions
Digital image analysis was used to examine pathological
changes to villous architecture in patients with active
and treated malaria and controls. Villous area was sig-
nificantly correlated with vascularity and inversely corre-
lated with density of villi per unit area. UK controls
showed significantly greater villous area and vascularity
than Karen groups. There was a significant relationship
between villous number and anaemia at the time of in-
fection, but not placental weight and gestational age at
delivery. Active malaria-infected cases showed signifi-
cantly smaller villous area, vascularity, density, and per-
imeter measurement than controls. However increased
villous numbers in malaria cases caused a compensatory
increase in total available villous perimeter. Histology
score and villous architecture showed no significant dif-
ferences between infections with either P. falciparum,
P. vivax, or consecutive infections by both during the
course of pregnancy. These results imply that villous
architecture changes acutely during malaria infection,
causing shrinkage of the terminal villous and compensa-
tory increase in the number of villi which persists follow-
ing treatment and eradication of the infection. It cannot
be excluded that the reversal of placental morphological
changes may be related to improvement in maternal an-
aemia, caused by malarial treatment. However other archi-
tectural and pathological changes induced by malaria
infection are reversible given early detection and appropri-
ate anti-malarial treatment.
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